08:40 AM EDT, 09/29/2025 (MT Newswires) -- Shares of pot companies climbed in premarket trading on Monday after U.S. President Donald Trump advocated the potential benefits from the use of cannabidiol in senior healthcare in a social media post, Reuters is reporting Monday.

The report noted Trump had said last month his administration was looking to reclassify marijuana, which could also result in potentially easing criminal penalties around its use.

Hemp-derived cannabidiol (CBD) could "revolutionize senior healthcare" by helping reduce disease progression and was shown as an alternative to prescription drugs, he said in a post on Truth Social on Sunday.

U.S.-listed shares of Canopy Growth ( CGC ), and Tilray Brands ( TLRY ) had both jumped nearly 20% before the bell, while Cronos Group ( CRON ) added 9.5% and Aurora Cannabis ( ACB ) gained 13.7%, respectively.

(Market Chatter news is derived from conversations with market professionals globally, and/or from other media sources. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)